| Three-dimensional culture systems in cancer research: Focus on tumor spheroid model S Nath, GR Devi Pharmacology & therapeutics 163, 94-108, 2016 | 1014 | 2016 |
| MUC1: a multifaceted oncoprotein with a key role in cancer progression S Nath, P Mukherjee Trends in molecular medicine 20 (6), 332-342, 2014 | 877 | 2014 |
| MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition LD Roy, M Sahraei, DB Subramani, D Besmer, S Nath, TL Tinder, E Bajaj, ... Oncogene 30 (12), 1449-1459, 2011 | 323 | 2011 |
| MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes S Nath, K Daneshvar, LD Roy, P Grover, A Kidiyoor, L Mosley, M Sahraei, ... Oncogenesis 2 (6), e51-e51, 2013 | 192 | 2013 |
| MUC1 regulates PDGFA expression during pancreatic cancer progression M Sahraei, LD Roy, JM Curry, TL Teresa, S Nath, D Besmer, A Kidiyoor, ... Oncogene 31 (47), 4935-4945, 2012 | 99 | 2012 |
| X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity MK Evans, SJ Sauer, S Nath, TJ Robinson, MA Morse, GR Devi Cell death & disease 7 (1), e2073-e2073, 2016 | 61 | 2016 |
| Mucin 1 regulates Cox-2 gene in pancreatic cancer S Nath, LD Roy, P Grover, S Rao, P Mukherjee Pancreas 44 (6), 909-917, 2015 | 45 | 2015 |
| SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line P Grover, S Nath, MD Nye, R Zhou, M Ahmad, P Mukherjee Oncotarget 9 (6), 6897, 2018 | 36 | 2018 |
| MicroRNA miR-308 regulates dMyc through a negative feedback loop in Drosophila K Daneshvar, S Nath, A Khan, W Shover, C Richardson, JM Goodliffe Biology Open 2 (1), 1-9, 2012 | 23 | 2012 |
| Pancreatic cancer cells isolated from Muc1-null tumors favor the generation of a mature less suppressive MDSC population A Kidiyoor, J Schettini, DM Besmer, SL Rego, S Nath, JM Curry, LD Roy, ... Frontiers in Immunology 5, 67, 2014 | 21 | 2014 |
| Overexpression of MUC1 induces non-canonical TGF-β signaling in pancreatic ductal adenocarcinoma M Bose, P Grover, AJ Sanders, R Zhou, M Ahmad, S Shwartz, P Lala, ... Frontiers in cell and developmental biology 10, 821875, 2022 | 19 | 2022 |
| Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic and breast cancer murine models M Sahraei, M Bose, JA Sanders, C De, L DasRoy, S Nath, CR Brouwer, ... International journal of molecular sciences 22 (11), 5587, 2021 | 18 | 2021 |
| Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice JM Curry, DM Besmer, TK Erick, N Steuerwald, L Das Roy, P Grover, ... PLoS One 14 (11), e0224309, 2019 | 18 | 2019 |
| P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO … G Koehne, B Tomlinson, H Suh, D Koura, C Cho, NM Bambace, ... HemaSphere 7 (S3), e24418bc, 2023 | 6 | 2023 |
| Phase 1/2 study of donor-derived anti-cD33 chimeric antigen receptor expressing t cells (vcAR33) in patients with relapsed or refractory acute myeloid leukemia after allogeneic … NN Shah, J Azzi, BW Cooper, A Deol, J DiPersio, D Koura, B McClune, ... Blood 142, 4862, 2023 | 5 | 2023 |
| Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Shows Rapid Primary Engraftment with CD33-Negative Hematopoiesis in Patients with High-Risk Acute Myeloid Leukemia … JF DiPersio, B Cooper, HC Suh, D Koura, L Bernard, NN Shah, RB Walter, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | 3 | 2024 |
| Trem-cel, a CRISPR/Cas9 gene-edited allograft lacking CD33, shows rapid primary engraftment with CD33-negative hematopoiesis in patients with high-risk acute myeloid leukemia … J DiPersio, BW Cooper, HC Suh, D Koura, L Bernard, NN Shah, ... Blood 142, 483, 2023 | 3 | 2023 |
| Trial in Progress: a first-in-human phase 1/2 study of hematopoietic stem cell transplantation (HCT) with VOR33 (CD33-deleted allograft) followed by treatment with gemtuzumab … BW Cooper, HC Suh, D Koura, G Koehne, C Cho, NM Bambace, ... Blood 140 (Supplement 1), 12973-12975, 2022 | 2 | 2022 |
| Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic ductal adenocarcinoma and breast cancer murine models S Mahnaz, LD Roy, M Bose, C De, S Nath, P Mukherjee bioRxiv, 2020.12. 07.415299, 2020 | 2 | 2020 |
| Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy GR Devi, S Nath Synthetic mRNA: Production, Introduction Into Cells, and Physiological …, 2016 | 2 | 2016 |
